Literature DB >> 33742011

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis.

Natalia Roberto1,2, Maria J Portella3,4,5, Marta Marquié6,7, Montserrat Alegret6,7, Isabel Hernández6,7, Ana Mauleón6, Maitee Rosende-Roca6, Carla Abdelnour6,7, Ester Esteban de Antonio6, Silvia Gil6,7, Juan P Tartari6, Liliana Vargas6, Ana Espinosa6,7, Gemma Ortega6,7, Alba Pérez-Cordón6, Ángela Sanabria6,7, Adelina Orellana6,8, Itziar de Rojas6, Sonia Moreno-Grau6, Laura Montrreal6, Emilio Alarcón-Martín6, Agustín Ruíz6,7, Lluís Tárraga6,7, Mercè Boada6,7, Sergi Valero6,7.   

Abstract

Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer's disease (AD) and other dementia types in patients diagnosed with Mild Cognitive Impairment (MCI). Our aim was to determine profiles based on the prominent NPS in MCI patients and to explore the predictive value of these profiles on conversion to specific types of dementia. A total of 2137 MCI patients monitored in a memory clinic were included in the study. Four NPS profiles emerged (classes), which were defined by preeminent symptoms: Irritability, Apathy, Anxiety/Depression and Asymptomatic. Irritability and Apathy were predictors of conversion to dementia (HR = 1.43 and 1.56, respectively). Anxiety/depression class showed no risk effect of conversion when compared to Asymptomatic class. Irritability class appeared as the most discriminant neuropsychiatric condition to identify non-AD converters (i.e., frontotemporal dementia, vascular dementia, Parkinson's disease and dementia with Lewy Bodies). The findings revealed that consistent subgroups of MCI patients could be identified among comorbid basal NPS. The preeminent NPS showed to behave differentially on conversion to dementia, beyond AD. Therefore, NPS should be used as early diagnosis facilitators, and should also guide clinicians to detect patients with different illness trajectories in the progression of MCI.

Entities:  

Year:  2021        PMID: 33742011     DOI: 10.1038/s41598-021-83126-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  28 in total

1.  The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

Authors:  S Gao; H C Hendrie; K S Hall; S Hui
Journal:  Arch Gen Psychiatry       Date:  1998-09

2.  Risk factors of transition from mild cognitive impairment to Alzheimer's disease and death: A cohort study.

Authors:  Haihong Xue; Qianqian Sun; Long Liu; Liye Zhou; Ruifeng Liang; Runlian He; Hongmei Yu
Journal:  Compr Psychiatry       Date:  2017-07-18       Impact factor: 3.735

3.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 4.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

5.  Progression of mild cognitive impairment to dementia due to AD in clinical settings.

Authors:  Karim Tifratene; Philippe Robert; Asya Metelkina; Christian Pradier; Jean François Dartigues
Journal:  Neurology       Date:  2015-07-01       Impact factor: 9.910

6.  Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky
Journal:  Arch Neurol       Date:  2007-03

7.  Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

Authors:  A J Mitchell; M Shiri-Feshki
Journal:  Acta Psychiatr Scand       Date:  2008-02-18       Impact factor: 6.392

8.  Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

Authors:  Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky
Journal:  JAMA       Date:  2002-09-25       Impact factor: 56.272

Review 9.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

10.  Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.

Authors:  Pedro J Modrego; Jaime Ferrández
Journal:  Arch Neurol       Date:  2004-08
View more
  8 in total

Review 1.  Cognitive impairment and World Trade Centre-related exposures.

Authors:  Sean A P Clouston; Charles B Hall; Minos Kritikos; David A Bennett; Steven DeKosky; Jerri Edwards; Caleb Finch; William C Kreisl; Michelle Mielke; Elaine R Peskind; Murray Raskind; Marcus Richards; Richard P Sloan; Avron Spiro; Neil Vasdev; Robert Brackbill; Mark Farfel; Megan Horton; Sandra Lowe; Roberto G Lucchini; David Prezant; Joan Reibman; Rebecca Rosen; Kacie Seil; Rachel Zeig-Owens; Yael Deri; Erica D Diminich; Bernadette A Fausto; Sam Gandy; Mary Sano; Evelyn J Bromet; Benjamin J Luft
Journal:  Nat Rev Neurol       Date:  2021-11-18       Impact factor: 42.937

Review 2.  Transcranial magnetic stimulation (TMS) for geriatric depression.

Authors:  Davide Cappon; Tim den Boer; Caleb Jordan; Wanting Yu; Eran Metzger; Alvaro Pascual-Leone
Journal:  Ageing Res Rev       Date:  2021-11-25       Impact factor: 10.895

3.  Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer's Disease Dementia: A Latent Class Analysis.

Authors:  Maitée Rosende-Roca; Pilar Cañabate; Mariola Moreno; Silvia Preckler; Susana Seguer; Ester Esteban; Juan Pablo Tartari; Liliana Vargas; Leire Narvaiza; Vanesa Pytel; Urszula Bojaryn; Emilio Alarcon; Antonio González-Pérez; Miren Jone Gurruchaga; Lluís Tárraga; Agustín Ruiz; Marta Marquié; Mercè Boada; Sergi Valero
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 4.  Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

Authors:  Ranjan Duara; Warren Barker
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

5.  Reward System Dysfunction and the Motoric-Cognitive Risk Syndrome in Older Persons.

Authors:  Fulvio Lauretani; Crescenzo Testa; Marco Salvi; Irene Zucchini; Beatrice Lorenzi; Sara Tagliaferri; Chiara Cattabiani; Marcello Maggio
Journal:  Biomedicines       Date:  2022-03-30

6.  Measuring neuropsychiatric symptoms in patients with early cognitive decline using speech analysis.

Authors:  Alexandra König; Elisa Mallick; Johannes Tröger; Nicklas Linz; Radia Zeghari; Valeria Manera; Philippe Robert
Journal:  Eur Psychiatry       Date:  2021-10-13       Impact factor: 5.361

7.  Prodromal frontotemporal dementia: clinical features and predictors of progression.

Authors:  Alberto Benussi; Nicholas J Ashton; Thomas K Karikari; Antonella Alberici; Claudia Saraceno; Roberta Ghidoni; Luisa Benussi; Henrik Zetterberg; Kaj Blennow; Barbara Borroni
Journal:  Alzheimers Res Ther       Date:  2021-11-15       Impact factor: 6.982

8.  Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.

Authors:  Natalia Roberto; Maria J Portella; Marta Marquié; Montserrat Alegret; Isabel Hernández; Ana Mauleón; Maitee Rosende-Roca; Carla Abdelnour; Ester Esteban de Antonio; Juan P Tartari; Liliana Vargas; Rogelio López-Cuevas; Urszula Bojaryn; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Adelina Orellana; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Emilio Alarcón-Martín; Agustín Ruíz; Lluís Tárraga; Mercè Boada; Sergi Valero
Journal:  Front Aging Neurosci       Date:  2021-12-08       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.